Chong Kun Dang Pharmaceutical Corp.
Symbol: 185750.KS
KSC
101200
KRWTrhová cena dnes
6.5327
Pomer P/E
0.2409
Pomer PEG
1.29T
MRK Cap
- 0.01%
Výnos DIV
Chong Kun Dang Pharmaceutical Corp. (185750-KS) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 977306.91 | 365065.3 | 155861.2 | 187332.6 | |||||||||||
balance-sheet.row.short-term-investments | 234574.58 | 145418.9 | 38444.3 | 55519.9 | |||||||||||
balance-sheet.row.net-receivables | 1166084.87 | 311468.6 | 287306.6 | 234703.7 | |||||||||||
balance-sheet.row.inventory | 1101639.04 | 261431.9 | 270081.5 | 224722.9 | |||||||||||
balance-sheet.row.other-current-assets | 9554.78 | 8606.1 | 365.5 | 20387.9 | |||||||||||
balance-sheet.row.total-current-assets | 3254585.6 | 946571.9 | 713614.8 | 667147.2 | |||||||||||
balance-sheet.row.property-plant-equipment-net | 1263852.99 | 319787.1 | 310697.4 | 298909.7 | |||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.intangible-assets | 176043.64 | 52527.1 | 26953 | 20805.5 | |||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 176043.64 | 52527.1 | 26953 | 20805.5 | |||||||||||
balance-sheet.row.long-term-investments | 110109.3 | 67179.1 | 5565.5 | -22146.7 | |||||||||||
balance-sheet.row.tax-assets | 35440.27 | 14213.2 | 6208.6 | 2350.3 | |||||||||||
balance-sheet.row.other-non-current-assets | 186897.57 | 2150.1 | 61843.5 | 79634.1 | |||||||||||
balance-sheet.row.total-non-current-assets | 1772343.77 | 455856.6 | 411268 | 379552.9 | |||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.total-assets | 5026929.37 | 1402428.4 | 1124882.8 | 1046700.1 | |||||||||||
balance-sheet.row.account-payables | 677227.23 | 183938.8 | 145436.3 | 129327.4 | |||||||||||
balance-sheet.row.short-term-debt | 615980.74 | 184767.4 | 124445.5 | 102091.4 | |||||||||||
balance-sheet.row.tax-payables | 130003.78 | 43938.2 | 29026.4 | 18701.1 | |||||||||||
balance-sheet.row.long-term-debt-total | 301223.13 | 30000 | 111292.6 | 134962.3 | |||||||||||
Deferred Revenue Non Current | 14490.66 | 1484.8 | 6438.3 | 5982 | |||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 21900.45 | - | - | - | |||||||||||
balance-sheet.row.other-current-liab | 286154.11 | 134996.6 | 98922.3 | 20691.5 | |||||||||||
balance-sheet.row.total-non-current-liabilities | 395681.85 | 75327.4 | 129380.9 | 160660.6 | |||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.capital-lease-obligations | 31147.98 | 4996.5 | 1694.2 | 3470.5 | |||||||||||
balance-sheet.row.total-liab | 2153650.5 | 586793.3 | 503594 | 480890.4 | |||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||
balance-sheet.row.common-stock | 125684.64 | 31421.2 | 29970.1 | 28565.2 | |||||||||||
balance-sheet.row.retained-earnings | 1554612.31 | 218102.4 | 376370.8 | 302106.6 | |||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1404661.23 | 350829.8 | 276706.4 | 250156.9 | |||||||||||
balance-sheet.row.other-total-stockholders-equity | -210144.4 | 215341.1 | -60654.3 | -14818.7 | |||||||||||
balance-sheet.row.total-stockholders-equity | 2874813.78 | 815694.5 | 622393.1 | 566010 | |||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 5026929.37 | 1402428.4 | 1124882.8 | 1046700.1 | |||||||||||
balance-sheet.row.minority-interest | -1534.92 | -59.3 | -1104.3 | -200.3 | |||||||||||
balance-sheet.row.total-equity | 2873278.86 | 815635.2 | 621288.8 | 565809.6 | |||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 5026929.37 | - | - | - | |||||||||||
Total Investments | 344683.88 | 212598 | 44009.8 | 33373.2 | |||||||||||
balance-sheet.row.total-debt | 922200.38 | 219763.9 | 235738.1 | 237053.8 | |||||||||||
balance-sheet.row.net-debt | 179468.05 | 117.5 | 118321.2 | 105241.1 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 213740.93 | 212521.2 | 79977.8 | 42356.5 | |||||||||||
cash-flows.row.depreciation-and-amortization | 37007.96 | 36942.2 | 33597.7 | 27481.9 | |||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||
cash-flows.row.change-in-working-capital | 29681.84 | 29681.8 | -77299.3 | -71568.7 | |||||||||||
cash-flows.row.account-receivables | -29559.69 | -29559.7 | -51435.9 | -6926 | |||||||||||
cash-flows.row.inventory | -5980.26 | -5980.3 | -54466.2 | -53770.6 | |||||||||||
cash-flows.row.account-payables | 38583.78 | 38583.8 | 15824.5 | -15597.8 | |||||||||||
cash-flows.row.other-working-capital | 26638.01 | 26638 | 12778.2 | 4725.7 | |||||||||||
cash-flows.row.other-non-cash-items | 37729.17 | 39014.7 | 31458.4 | 14634.2 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 318159.91 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -68806.05 | -68806 | -53064.7 | -51844.4 | |||||||||||
cash-flows.row.acquisitions-net | 20636.77 | 451.6 | 142.1 | -3448.7 | |||||||||||
cash-flows.row.purchases-of-investments | -192468.23 | -192468.2 | -57181.1 | -61266.4 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 89470.04 | 89470 | 44375.6 | 21934.7 | |||||||||||
cash-flows.row.other-investing-activites | -20145.43 | 39.8 | 347.8 | 3815.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -171312.9 | -171312.9 | -65380.3 | -90809.3 | |||||||||||
cash-flows.row.debt-repayment | -44714.6 | -22714.6 | -0.3 | -896.2 | |||||||||||
cash-flows.row.common-stock-issued | 0 | -3335.3 | 0 | 0 | |||||||||||
cash-flows.row.common-stock-repurchased | -6024.99 | -6025 | -1888.4 | -1935.3 | |||||||||||
cash-flows.row.dividends-paid | 0 | -11608.5 | -11238.8 | -10808.3 | |||||||||||
cash-flows.row.other-financing-activites | 18648.14 | -16.5 | -3212.4 | 98778.7 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -43699.98 | -43700 | -16339.8 | 85138.9 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -917.57 | -917.6 | -410.1 | 920.1 | |||||||||||
cash-flows.row.net-change-in-cash | 102229.45 | 102229.4 | -14395.8 | 8153.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 742732.33 | 219646.3 | 117416.9 | 131812.7 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 640502.88 | 117416.9 | 131812.7 | 123659.1 | |||||||||||
cash-flows.row.operating-cash-flow | 318159.91 | 318159.9 | 67734.5 | 12903.9 | |||||||||||
cash-flows.row.capital-expenditure | -68806.05 | -68806 | -53064.7 | -51844.4 | |||||||||||
cash-flows.row.free-cash-flow | 249353.86 | 249353.9 | 14669.8 | -38940.5 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1657673.31 | 1669404.4 | 1488344.7 | 1343559.4 | |||||||||||
income-statement-row.row.cost-of-revenue | 779200.12 | 1014059.9 | 945705.3 | 847741.1 | |||||||||||
income-statement-row.row.gross-profit | 878473.19 | 655344.5 | 542639.4 | 495818.3 | |||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||
income-statement-row.row.research-development | 104406.15 | - | - | - | |||||||||||
income-statement-row.row.selling-general-administrative | 199875.81 | - | - | - | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 80977.59 | - | - | - | |||||||||||
income-statement-row.row.other-expenses | -716317.4 | -11694.4 | 139957.4 | 135069 | |||||||||||
income-statement-row.row.operating-expenses | 249710.32 | 408657.6 | 432733.3 | 401059.6 | |||||||||||
income-statement-row.row.cost-and-expenses | 1222350.41 | 1422717.5 | 1378438.7 | 1248800.7 | |||||||||||
income-statement-row.row.interest-income | 4775.61 | 5789.3 | 2139 | 716.2 | |||||||||||
income-statement-row.row.interest-expense | 7001.12 | 9271 | 6846.9 | 4029.9 | |||||||||||
income-statement-row.row.selling-and-marketing-expenses | 80977.59 | - | - | - | |||||||||||
income-statement-row.row.total-other-income-expensenet | 1.88 | -5283.9 | -12741 | -14164.8 | |||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||
income-statement-row.row.other-operating-expenses | -716317.4 | -11694.4 | 139957.4 | 135069 | |||||||||||
income-statement-row.row.total-operating-expenses | 1.88 | -5283.9 | -12741 | -14164.8 | |||||||||||
income-statement-row.row.interest-expense | 7001.12 | 9271 | 6846.9 | 4029.9 | |||||||||||
income-statement-row.row.depreciation-and-amortization | 202519.12 | 36942.2 | 34919.3 | 18187.3 | |||||||||||
income-statement-row.row.ebitda-caps | 444402.06 | - | - | - | |||||||||||
income-statement-row.row.operating-income | 241882.93 | 246686.9 | 109906.1 | 94758.7 | |||||||||||
income-statement-row.row.income-before-tax | 241884.82 | 241403 | 97165.1 | 80593.9 | |||||||||||
income-statement-row.row.income-tax-expense | 39271.89 | 27995.7 | 17187.3 | 38237.4 | |||||||||||
income-statement-row.row.net-income | 201766.15 | 212521.2 | 80953.4 | 42720.4 |
Často kladené otázky
Čo je Chong Kun Dang Pharmaceutical Corp. (185750.KS) celkové aktíva?
Chong Kun Dang Pharmaceutical Corp. (185750.KS) celkové aktíva sú 1402428435512.000.
Aký je ročný obrat podniku?
Ročné príjmy sú 858061047502.000.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.530.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 19599.181.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.122.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.146.
Aká je Chong Kun Dang Pharmaceutical Corp. (185750.KS) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 212521171440.000.
Aký je celkový dlh firmy?
Celkový dlh je 219763880100.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 408657610015.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 219646348416.000.